Tag: ALLEGRO-LT

Ritlecitinib also effective in patients with total hair loss

Presented By
Dr Melissa Piliang, Cleveland Clinic, USA
Trial
Phase 3, ALLEGRO
Conference
AAD 2024
Type
Peer-reviewed article

22 April 2024 14:57

JAK3/TEC inhibition achieves clinically meaningful responses in AA

Presented By
Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany
Trial
Phase 3, ALLEGRO-LT
Conference
EADV 2023
Type
Peer-reviewed article

28 November 2023 10:31

Can ritlecitinib deliver long-term efficacy in alopecia areata?

Presented By
Prof. Melissa Piliang, Cleveland Clinic, OH, USA
Trial
Phase 3, ALLEGRO
Conference
WCD 2023
Type
Peer-reviewed article

31 August 2023 15:18

The rise of JAK inhibitors for alopecia areata

Presented By
Dr Brett King, Yale University, CT, USA
Conference
DDD 2023
Type
Peer-reviewed article

10 May 2023 13:47

Long-term improvement in alopecia areata with ritlecitinib therapy

Presented By
Dr Athanasios Tsianakas, Fachklinik Bad Bentheim, Germany
Trial
Phase 3, ALLEGRO-LT
Conference
EADV 2022
Type
Peer-reviewed article

5 November 2022 09:30
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com